Sales & Marketing Disrupted medical conferences: Lessons learnt The new normal is already here. Get used to it.
Views & Analysis Are face-to-face medical meetings a thing of the past? Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception.
Views & Analysis What pharma can do to win in virtual Early data indications from the first virtual congresses shows big changes are needed.
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
